← FDA DRUG APPROVALS

FDA ANDA · ANDA208150

FLUTICASONE PROPIONATE

Sponsor: APOTEX

APPLICATION
ANDA208150
TYPE
ANDA
ORIGINAL APPROVAL
2016-02-29
LATEST ACTION
2017-10-20
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Over-the-counter

Products

FLUTICASONE PROPIONATEOver-the-counter
FLUTICASONE PROPIONATE 0.05MG/SPRAY · SPRAY, METERED · NASAL

Approval history

2017-10-20Labeling · Supplement 5 · standardAP
2016-02-29UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →